GlobeNewswire
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
📈
AI Sentiment
Highly Positive
8/10
Cocrystal Pharma Inc. News
Latest updates and market news for COCP
1 news
Mar 7 - Mar 13, 2026
Page 1
Share this news page